| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 596,400 | 634,200 | 616,800 | 617,100 | | Cost of Revenue | 224,300 | 243,500 | 239,500 | 243,600 | | | Gross Profit | 372,100 | 390,700 | 377,300 | 373,500 | | | Operating Expenses | | Research Development | 36,400 | 40,000 | 35,100 | 38,200 | | Selling General and Administrative | 173,600 | 179,200 | 180,600 | 180,800 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 162,100 | 171,500 | 161,600 | 154,500 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (2,700) | 1,900 | (32,600) | | Earnings Before Interest And Taxes | 162,100 | 168,800 | 163,500 | 121,900 | | Interest Expense | 3,000 | 3,000 | 3,100 | 3,000 | | Income Before Tax | 159,100 | 165,800 | 160,400 | 118,900 | | Income Tax Expense | 45,900 | 16,400 | 49,200 | 41,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 113,200 | 149,400 | 111,200 | 77,900 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 113,200 | 149,400 | 111,200 | 77,900 | | Preferred Stock And Other Adjustments | (700) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $112,500 | $149,400 | $111,200 | $77,900 |
|
0.45% Nasdaq 
0.20%
Income Statement
